Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

We report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented with primary tumor in situ in the left kidney and metastases to bone, liver, lungs, and brain. After over 5 years of sunitinib therapy and subsequent cytoreductive left nephrectomy, the patient achieved radiogra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Urol Case Rep
Main Authors: Shah, Amishi Y., Karam, Jose A., Lim, Zita D., Ng, Chaan S., Tannir, Nizar M.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2015
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477704/
https://ncbi.nlm.nih.gov/pubmed/26120560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2014.12.011
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares